Researchers from CNAG, IBEC and IRB Barcelona receive funding from La Marató 2018 Blog Post

Yesterday, the Fundació La Marató de TV3 announced the research teams of excellence that will receive funding thanks to 15 million euros, a record amount, collected in the last edition of the program, for cancer research. Collaborative projects involving researchers from three centres located in the Barcelona Science Park (PCB) are among the winners, namely the Centro Nacional de Análisis Genómico (CNAG-CRG), the Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona). 

 

Home stroke recovery thanks to virtual reality Blog Post

Today is the World Stroke Day, a medical condition that affects to 14.5 million people every year and it is the leading cause of death in women and the second cause in men. Health innovation contributes speeding up recovery of patients and it drastically reduces the number of visits to clinic as well as the duration of treatment in hospitals and therapy centres. It also reduces costs at the health public system. In these cases, technology can be a powerful ally, as can be seen from EIT Health Innovation Projects. EIT Health Spain, the Spanish Co-Location Center (CLC) of EIT Health, is headquartered at the Barcelona Science Park.

 

Scientists build machine learning-based algorithm to predict which cancer patients benefit from immunotherapy Blog Post

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, in collaboration with the Centre for Genomic Regulation (CRG) and Radboud University, have built a tool that detects genetic mutations that trigger the immune system, helping identify which cancer patients are more likely to benefit from immunotherapy. The algorithm also reveals which people living with hereditary diseases may benefit from drugs that already exist. The new technology’s potential is described today in Nature Genetics.

 

The biotechnology company Aromics has been recognized as one of the most innovative Biotecs at the Sino-Europe Healthtech Innovation Week in China Blog Post

The Horizon 2020 project BERMES aimed to develop a novel therapy for malignant mesothelioma, lead by the catalan biotech company Aromics, was recognized as one of the most innovative initiatives at the Sino-Europe Innovation Week of Health Technology which was held from 12th to 16th October at two of the most technological and powerful cities in China: Nanjing and Shanghai. The biotechnology company, located at the Barcelona Science Park, participated in the event as part of a mission organized by the BioRegion of Catalonia to explore new opportunities for collaboration with Chinese companies and institutions and to learn about the experience of other European clusters in the Asian giant.

 

Molomics opens an investment round to accelerate an innovative project against Parkinson’s Blog Post

Molomics Biotech, based in the Barcelona Science Park, has just opened a financing round of 400,000 euros through the online investment platform Capital Cell, allowing also small private investors to acquire shares of the company. With this capital increase, the Spanish startup –which has a financial and professional support of the Michael J. Fox Foundation wants to enter the preclinical phase with an innovative treatment to fight involuntary movements (dyskinesias) associated with Parkinson’s.

 

GlyCardial begins the clinical trial of its novel diagnostic device for myocardial ischemia Blog Post

GlyCardial Diagnostics, located at the Barcelona Science Park, has announced the enrolment of the first two patients in the EDICA trial: a multicenter international clinical study for the early detection of myocardial ischaemia. The company –a spinoff of the Research Institute of the Hospital de la Santa Creu i Sant Pau (IR-HSCSP) and the Spanish National Research Council (CSIC), has developed innovative technology for the detection of Apo J-Glyc protein, as a novel biomarker in blood for the diagnosis and prognosis of myocardial ischemia, and expects to demonstrate the reliability of the new test in hospital laboratories.

 

New Born Solutions chosen to take part in the EIT Health Digital Sandbox Blog Post

New Born Solutions, based in the Barcelona Science Park (PCB), was one of the 10 small and medium-sized enterprises chosen to take part in the Digital Sandbox accelerator programme developed by EIT Health, the Knowledge and Innovation in Health Community, promoted by the European Institute of Innovation & Technology (EIT). The winning start-ups, chosen from around thirty applicants from all over Europe, will receive advisory services and up to €35,000 in funding to develop products and services making use of the data available on biobanks and quality registers in Europe.

 

IBEC obtains a second accreditation as Severo Ochoa Centre of Excellence Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, is one of the six centres in Spain to be awarded accreditation in this round of the Severo Ochoa Excellence programme. Furthermore, IBEC is the only center that receives this accreditation for the second time. The awards last for four years and bring a million euros each year to the winning centres, it also implies strengthening research capacities and boosting success rates in other competitive funding programmes.